PedroPiedraMD
Pediatric Infectious Disease • Houston, TXProfessor, Virology & Microbiology, Baylor College of Medicine
Dr. Piedra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1504 Taub Loop
Houston, TX 77030Phone+1 713-873-5437Fax+1 713-873-4337
Education & Training
University at BuffaloFellowship, Pediatric Infectious Diseases, 1984 - 1987
Medical University of South CarolinaResidency, Pediatrics, 1981 - 1984
University of South Florida College of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1988 - 2025
SC State Medical License 1982 - 1984
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.Heidi L Moline, Ariana P Toepfer, Ayzsa Tannis, Geoffrey A Weinberg, Mary A Staat
JAMA Pediatrics. 2025-02-01 - Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load.Vasanthi Avadhanula, Chad J Creighton, Laura Ferlic-Stark, Divya Nagaraj, Yiqun Zhang
Plos One. 2025-01-01 - 2 citationsInfant-derived human nasal organoids exhibit relatively increased susceptibility, epithelial responses, and cytotoxicity during RSV infection.Gina M Aloisio, Divya Nagaraj, Ashley M Murray, Emily M Schultz, Trevor McBride
The Journal of Infection. 2024-12-01
Other
- Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-03-13 - Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-01-09
Press Mentions
More Information Needed Amid Paused RSV Vaccine for Children, FDA Committee SaysDecember 14th, 2024
FluMist: Who Is the Nasal Spray Best For?October 22nd, 2024- COVID, Flu and RSV: Know the Vaccines for These Three Common Respiratory VirusesSeptember 4th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
